[An experimental study of inhibiting effect of decoy oligodeoxynucleotides on the gene expression of collagen in NIH3T3 cell].

Tian-zhi Hao,Huan-ping Liang,Feng-lin Lv,Xiang Xu,Hua Guo,Fu-long Wang,Wen-jun Yang,Yan Luo,Lei Li

DOI: https://doi.org/10.3760/cma.j.issn.1009-2587.2003.03.015

2003-01-01

Abstract:Decoy-ODNs could inhibit the mRNA expression of fibroblast alpha2 type I collagen by antagonizing AP-1.

What problem does this paper attempt to address?

Decoy Oligonucleotide Rescues IGF1R Expression from MicroRNA-223 Suppression.

Li Hui Wu,Qian,Yi Wei Dong,Rong Wang,Bao Mei He,Bing Qi,Chang Jun Xu,Xing Zhong Wu

DOI: https://doi.org/10.1371/journal.pone.0082167

IF: 3.7

2013-01-01

PLoS ONE

Abstract:A mature miRNA generally suppresses hundreds of mRNA targets. To evaluate the selective effect of synthetic oligonucleotide decoys on hsa-miR-223 activity, reporters containing 3' untranslated regions (UTR) of IGF1R, FOXO1, POLR3G, FOXO3, CDC27, FBXW7 and PAXIP1 mRNAs were constructed for the luciferase assay. The oligonucleotide decoys were designed and synthesized according to mature miR-223 sequence and its target mRNA sequence. Quantitative RT-PCR & western analysis were used to measure miR-223-targeted mRNA expression, Interestingly, apart from the antisense oligonucleotide, decoy nucleotides which were complementary to the 5', central or 3' region of mature miR-223 suppressed miR-223 targeting the 3'UTR of IGF1R, FOXO1, FOXO3, CDC27, POLR3G, and FBXW7 mRNAs and rescued the expression of these genes to varying degrees from miR-223 suppression at both mRNA and protein levels. All decoys had no effect on PAXIP1 which was not targeted by miR-223. The decoy 1 that was based on the sequence of IGF1R 3'UTR rescued the expression of IGF1R more significantly than other decoy nucleotides except the antisense decoy 4. Decoy 1 also rescued the expression of FOXO3 and POLR3G of which their 3'UTRs have similar binding sites for miR-223 with IGF1R 3'UTR. However decoy 1 failed to recover Sp1, CDC27 and FBXW7 expression. These data support that the sequence-specific decoy oligonucleotides might represent exogenous competing RNA which selectively inhibits microRNA targeting.
Effect of Decoy Oligonucleotides of Nuclear Factor-kB on Intercellular Adhesion Molecule-1 Expression in Human Vascular Endothelial Cells

陈桢玥,陆国平

DOI: https://doi.org/10.3969/j.issn.1007-3949.2004.03.014

2004-01-01

Abstract:Objective To investigate the effects of decoy oligonucleotides (ODNs) of NF-κB on expression of adhesion molecules induced by TNF-α in vitro. Methods The affinity and specificity of decoy ODNs of NF-κB to the transcription factor NF-κB were detected by electrophoretic mobility shift assay (EMSA). Intracellular uptake of FITC-labeled oligonucleotides was detected by fluorescence active cell sort (FACS). Adhesion molecules expression was determined by RT-PCR at RNA level, FACS at protein level. Results The data showed that decoy ODNs of NF-κB can bind with the transcription factor NF-κB and has strong affinity and specificity. The decoy ODNs can downregulate the expression of intercellular adhesion molecule-1 (ICAM-1) stimulated by TNF-α in human vascular endothelial cells (HUVECs). Conclusion These observations demonstrate that the decoy oligonucleotides of NF-κB can inhibit NF-κB-mediated activities and downregulate the expression of some gene product as ICAM-1 involved in atherosclerosis.
The study of nuclear factor kappa B decoy oligodeoxyribonucleotide on NO production of chondrocytes induced by IL-1β

JIAN-XIANG LIU,Jing-yuan DU,Shu-hua YANG,Ri-guang LIU,Cheng-qing YI,Xin-chun LI

DOI: https://doi.org/10.3760/j:issn:1007-7480.2005.06.007

2005-01-01

Abstract:Objective To investigate the feasibility of Decoy Nuclear factor kappa B oligodeoxyribonucleotide (decoy NF-kappa B ODN) on chondrocytes nitric oxide (NO) production induced by interleukin-1β (IL-1β). Methods Double strand NF-kappa B decoy ODN with fluorescein isothiocyanate(FITC) that could recognize and combine to NF-kappa B consensus binding site of rat iNOS gene was synthased and double strand scambled NF-kappa B decoy ODN without FITC that could not recognize and combine to NF-kappa B consensus binding site was also sythased as control. Rat chondrocytes were isolated and cultured, scrambled NF-kappa B ODN and NF-kappa B decoy ODN were transfected into rat chondrocytes (0.5? 1? 2? 4? 8? 24? 48? 72 hours later, chondrocytes and were observed through fluroscenscopy) to determine the transfection efficacy and the degradation of ODN. Following this, 10 μmol/L scrambled NF-kappa B ODN and different concentrations of NF-kappa B decoy ODN were transfected into chondrocytes before IL-1β induction. NO assay kit and RT-PCR were used to detect the NO production and iNOS mRNA transcription. Result Double strand ODN could be transfected into chondrocyte nuclear and degraded 48 hours later. According to the concentration, concentrations above 4 μmol/L of NF-kappa B decoy ODN could inhibit NO production and iNOS mRNA transcription induced by IL-1β. Scrambled NF-kappa B decoy ODN had no such effect. Conclusion Decoy ODN can be transfected into chondrocytes. Decoy NF-kappa B ODN can inhibit NO production and iNOS mRNA transcription induced by IL-1β through decoy method. It provides a new theory and method to inhibite NO production for osteoarthritis treatment.
RNAi-mediated inhibition of COL1A1 and COL3A1 in human skin fibroblasts.

Qiong Wang,Zhenhui Peng,Shengxiang Xiao,Songmei Geng,Jingyi Yuan,Zhengxiao Li

DOI: https://doi.org/10.1111/j.1600-0625.2007.00574.x

2007-01-01

Experimental Dermatology

Abstract:Types I and III collagens are the major collagens comprising skin connective tissue. Defects in these collagens lead to diseases of dermal connective tissue and fibre hyperplasia. RNA interference (RNAi) provides a powerful tool to inhibit specific gene expression. In this study, we generated small interfering RNAs (siRNA) expression cassettes (SECs) by polymerase chain reaction (PCR) as a method to quickly screen the efficacy of siRNAs. We then cloned the most efficient SECs into vectors, using a rapid and novel method intrinsic to the design of the SEC, and transfected human skin fibroblasts (HSF) to generate stable lines. We show that the transfection of SECs into HSFs resulted in specific and effective repression of COL1A1 and COL3A1 expression (5.00% and 6.48% of control levels) provided a rapid method for testing candidate siRNA sequences. We report the use of vector-based RNAi to establish stable HSF cell lines with persistent knockdown over at least 30 days (25.21% and 22.12% of control levels). These stably modified HSF cell lines may be used for the study of other types of collagen or proteins of the extracellular matrix (ECM).
Suppression of cell proliferation and collagen production in cultured human hypertrophic scar fibroblasts by Sp1 decoy oligodeoxynucleotide.

Chenliang Deng,Jianghong Zheng,Weidong Wan,Shixin Zhang,Zhi Ding,Guangyu Mao,Songlin Yang

DOI: https://doi.org/10.3892/mmr.2013.1278

IF: 3.423

2013-01-01

Molecular Medicine Reports

Abstract:Hypertrophic scars are characterized by the abnormal proliferation of fibroblasts and an overproduction of collagen. The Sp1 transcription factor is involved in the stimulation of collagen synthesis. A decoy oligonucleotide (ODN) targeting Sp1 was designed and transfected into hypertrophic scar fibroblasts (HSFs) cells using cationic liposomes. The transfection efficiency was determined by flow cytometry and was observed to be 85 +/- 7% (n=5). Specific binding of the Sp1 decoy ODN was monitored with an electrophoretic mobility shift assay (EMSA). Following transfection with the decoy ODN to Sp1, cell viability and cell proliferation, which were examined by the cell counting kit WST-8, were decreased by 80% compared with untreated cells. Transforming growth factor-beta (TGF-beta) mRNA and collagen mRNA expression were also reduced by 48% in the transfection decoy ODN group. The cell viability of HSFs after 48 h of transfection with 25, 50, 100 and 150 nM Sp1 decoy ODN was 0.9331 +/- 0.0203, 0.7479 +/- 0.0868, 0.577 +/- 0.0347 and 0.4703 +/- 0.0147, respectively. The 100 nM dose of the Sp1 decoy ODN inhibited the expression of types I and III collagen by 32 and 28%, respectively (both P<0.01). TGF-beta mRNA expression was also effectively suppressed by the 100 nM Sp1 decoy ODN (P<0.01). The Sp1 decoy ODN inhibited cell proliferation and the expression of types I and III collagen. Therefore, Sp1 decoy ODNs may be a promising tool for developing and testing novel therapeutic applications for treating hypertrophic scars.
Selective Inhibition of Collagen Gene Expression in Fibroblasts by an Interferon-Gamma Transgene

HA Jaffe,ZC Gao,Y Mori,LY Li,J Varga

DOI: https://doi.org/10.1080/019021499270268

1999-01-01

Experimental Lung Research

Abstract:Because interferon-gamma (IFN-gamma) selectively inhibits collagen gene expression, we hypothesized that expression of IFN-gamma cDNA in fibroblasts might be a useful strategy to inhibit the development of fibrosis. A replication-deficient E1(-), E3(-) adenovirus vector encoding murine IFN-gamma (AdCMVmIFN gamma) was constructed Infection of murine fibroblasts with AdCMVmIFN gamma in vitro was well tolerated. The results showed that IN F-gamma mRNA was expressed in infected cells, and as much as 17.7 ng of mIFN-gamma/10(6) cells was secreted into culture supernatants. Steady-state levels of alpha 1(I) procollagen mRNA were decreased by 90% in infected cells compared to uninfected cells. The inhibition of collagen mRNA expression was partially abrogated with a neutralizing anti-mIFN-gamma antibody. Secretion of total collagen by AdCMVmIFN gamma-infected fibroblasts was decreased by 60% compared to uninfected cells. Induction cells. Induction of cytokine responsive gene-2 expression in AdCMVmIFN gamma-infected cells demonstrated that suppression of collagen production was a selective response. The results suggest a novel strategy of cytokine gene transfer and expression for the treatment of fibrotic lung diseases.
Transfection of Nuclear Factor-Κb Decoy Oligodeoxynucleotide Inhibits Inflammatory Factors Expression in Renal Tubular Epithelial Cells

曹长春,李鹏,欧周罗,王磊,朱春芳,丁小强

DOI: https://doi.org/10.3760/j.issn:1001-7097.2003.04.010

2003-01-01

Abstract:Objective To evaluate the effect of NF-KB decoy oligodeoxynucleotides (ODN) strategy mediated by protamine liposome on NRK-52E renal tubular epithelial cells in vitro. Methods Lipsome (1 : 1 DOTAP/cholesterol) and ODNs complexes were prepared at + /-charge ratio of 4 and then transfected into TNF-αstimulated, complete cultured (contained 20% fetal bovine serum) NRK-52E cells. The transfection efficiency was observed by fluorescence microscope and evaluated by flow cytometry. NF-κB DNA binding abilities were analyzed by electrophoretic mobility shift assay (EMSA) . Genes expression of endothelin-1 (ET-1), iNOS, intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecular-1 (VCAM-1) and monocyte chemoattractant protein-1 (MCP-1) were assessed by reverse transcription polymerase chain reaction (RT-PCR). Results Mediated by protamine liposome produced high transfection efficiency compared to naked transfection (transcription efficiency was 93. 20% and 39. 0%, respectively) . NF-κB DNA binding abilities activated by TNF-α were abolished by NF-κB decoy ODN, instead of scrambled ODN. TNF-α-induced gene expression of ET-1, iNOS, ICAM-1, VCAM-1 and MCP-1 was significantly inhibited by NF-κB decoy ODN (all P 0. 01) . Conclusion Protamine liposome mediated ODN transfection method is highly efficient in vitro and not affected by serum. Transfection of NF-KB decoy ODN results in attenuation of NF-κB activities, leading to the inhibition of inflammatory genes expression in TNF-α activated renal tubular epithelial cells.
Inhibition of COL1A1 and COL3A1 Expression by RNA Interference in Human Skin Fibroblasts

Qiong Wang,Zhen-Hui Peng,Wan-Juan Wang

DOI: https://doi.org/10.3321/j.issn:1673-4254.2008.01.001

2008-01-01

Abstract:Objective To suppress COL1A1 and COL3A1 gene expressions in human skin fibroblasts (HSFs) by means of RNA interference (RNAi). Methods Three small interfering RNA (siRNA) expression cassette (SEC) sequences were designed for each of the COL1A1 and COL3A1 gene sequences available in GenBank. The synthesized SECs capable of effective gene suppression were transfected into cultured HSFs,either after cloning into the expression vector or mediated by Lipofectamine 2000,and the suppression of the target genes at both mRNA and protein levels was determined by quantitative fluorescence RT-PCR and Western blotting,respectively. Results Transfection of the SECs into HSFs resulted in specific depression of COL1A1 and COL3A1 expressions (down to 5.00% and 6.48%,respectively). The expression vector-mediated RNAi established a HSF cell line with persistent gene knockdown for over 30 days (to 25.21% and 22.12%,respectively). Conclusion COL1A1 and COL3A1 gene expressions can be specifically and efficiently inhibited in HSFs by either liposome-or vector-mediated SEC transfection.
Ultrasound-driven nanosilicon transfected tobacco cell as robust factory for collagen III protein synthesis

Ting-Wei Gu,Nan Zhou,Ying Xu,Yuda Liu,Minhong Tan,Jian‐Xiang Liu,Li‐Hua Peng

DOI: https://doi.org/10.21203/rs.3.rs-3232031/v1

2023-01-01

Abstract:Abstract Background: Therapeutic protein is one of the mostly used medications and the transgenic plant system offers an alternative to synthesis protein with simple practice and reduced infection issues. However, conventional plant transforming vehicles such as agrobacterium and electroporation have been hampered by limited transformation efficiency and biorisk. Methods: Herein, we describe an ultrasound driven nanosilicon composed hybrid-nanoplatform (named as UDSP), which can transform tobacco cells with high efficiency following a simple protocol. Results: With plasmid DNA encoding collagen III gene as a representative, UDSP demonstrates excellent transfection efficiency in tobacco cells with high efficacy to produce collagen III protein, with considerable number of exosomes containing collagen III (Col-Exo) produced simultaneously. The synthesized collagen III protein and Col-Exo are demonstrated for the obvious therapeutic effects in promoting wound regeneration and inflammation alleviation. Conclusions: UDSP transfected tobacco cell is shown as a promising biofactory with efficacy to synthesize recombinant proteins with intact tertiary structure, and therapeutic exosomes with target protein incorporated, with great potential in the protein synthesis and bioengineering.
Anti-Oxidant Gene Therapy by NFkB Decoy Oligodeoxynucleotide

Hironori Nakagami,Naruya Tomita,Yasufumi Kaneda,Toshio Ogihara,Ryuichi Morishita

DOI: https://doi.org/10.2174/138920106776597702

2006-04-01

Current Pharmaceutical Biotechnology

Abstract:Oxidative stress to cardiovascular cells induced by an interaction of multiple cytokines and adhesion molecules has been postulated to be responsible for cardiovascular disease. Since nuclear factor-kappaB (NFkappaB) also plays a pivotal role in the coordinated transactivation of cytokine and adhesion molecule genes, we utilized oligodeoxynucleotides (ODNs) as "decoy" cis-elements that block the binding of nuclear factors to promoter regions of targeted genes, resulting in the inhibition of gene transactivation. Indeed, transfection of NFkappaB decoy ODNs into coronary artery effectively prevented transactivation of essential cytokine and adhesion molecule protein expression, and thereby protected the myocardium from infarction. Transfection of NFkappaB decoy ODNs into balloon-injured carotid artery or porcine coronary artery markedly reduced neointimal formation. Thus, a clinical trial using NFkappaB decoy ODNs to treat restenosis was started in 2002. Recently, the therapeutic target utilizing NFkappaB decoy has been expanded to glomerulonephritis, rheumatoid arthritis, atopic dermatitis and osteoporosis. Moreover, the clinical trials to treat RA patients were initiated in 2003 and a Phase I/IIa human clinical trial using NFkappaB decoy ODNs to treat atopic dermatitis was initiated in December 2001. Topical application of NFkappaB decoy ODNs exhibited marked therapeutic effects on the facial skin condition of patients with atopic dermatitis. The covalently modified ODNs were developed by enzymatically ligating two identical molecules, thereby preventing their degradation by exonucleases. Indeed, the modified decoy ODNs possess increased nuclease resistance and are transported more efficiently into cells. Although there are still unresolved issues, decoy ODN drugs should become a reality.

pharmacology & pharmacy,biochemistry & molecular biology
[Influence of Nuclear Factor-Kappab Decoy Transfection on Nuclear Factor-Kappab Activity and Vascular Endothelial Growth Factor/urokinase-Type Plasminogen Activator/intercellular Cell Adhesion Molecule-1 Level of SKOV3 Cells].

Jian-ping Lu,Hong Sun,Chang-chun Cao,Zhou-luo Ou

DOI: https://doi.org/10.3760/j.issn:0529-567x.2004.08.009

2004-01-01

Abstract:OBJECTIVE:To investigate the effect of nuclear factor-kappaB (NF-kappaB) decoy oligodeoxynucleotides (ODN) on NF-kappaB activation and expressions of vascular endothelial growth factor (VEGF), urokinase-type plasminogen activator (uPA), intercellular cell adhesion molecule-1 (ICAM-1) of SKOV3 cell.METHODS:After transfected with NF-kappaB decoy ODN, SKOV3 cells were stimulated by IL-1beta and cultured for 6, 12, 24, and 48 h, respectively. NF-kappaB DNA binding activity was measured by gel mobility shift assay and mRNA levels of ICAM-1, uPA, VEGF were analyzed by RT-PCR and VEGF level in supernatant was detected by enzyme-linked immunosorbent assay (ELISA).RESULTS:(1) SKOV3 cells expressed constitutive NF-kappaB DNA binding activity and stimulation of IL-1beta resulted in a significant increase of the binding activity. NF-kappaB decoy ODN transfection significantly decreased constitutive level and elevated level of NF-kappaB DNA binding activity by IL-1beta at 6, 12, 24, and 48 h in vitro (P < 0.05). (2) The constitutive and activated mRNA levels of uPA, VEGF, ICAM-1 and VEGF levels in the supernatant were significantly inhibited by NF-kappaB decoy ODN transfection especially at 6 h after transfection in vitro.CONCLUSIONS:Both NF-kappaB DNA binding activity and expressions of uPA, VEGF, and ICAM-1 at 48 h were upregulated by IL-1beta, and inhibited by transfection with NF-kappaB decoy ODN in SKOV3 cell line. NF-kappaB decoy ODN transfection shows promise as a novel molecular approach for ovarian cancer.
Inhibitive effect of decoy oligonucleotides of transcription factor NF-κB and E2F on the proliferation of vascular smooth muscle cells

Rui Xi,Zhen-yue Chen,Jun Zhou,Chun-fang Wu,Guo-ping Lu

DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.09.042

2006-01-01

Abstract:AIM To probe into the inhibition effect of decoy oligonucleotides(ODNs)of transcription factor NF-κB and /or E2F on the proliferation of the vascular smooth muscle cells of porcine and its mechanism. METHODS This experiment was conducted at the Laboratory of Internal Medicine Ruijin Hospital from May 2004 to August 2005. ①We cultured porcine thoracic artery smooth muscle cells and synthesized ODNs in vitro. Cells were divided into 6 groups normal control group NF-κB decoy ODNs group E2F decoy ODNs group NF-κB+E2F decoy ODNs group NF-κB mismatched ODNs group E2F mismatched ODNs group and transfected by ODNs with liposome. We applied Laser Scanning Confocal microtechnic to observe the localization of ODNs labeled by FITC. ②Cells were stimulated by 0.1 fetal bovine serum after synchronized then methylthiazolyl tetrazolium assay MTTwas applied to detect the inhibition effect on proliferation. ③Western Blotting was used to detect the expression of proliferating cell nuclear antigenPCNA. ④We also used flow cytometry and phospholipids heptoglobin V method to analyze the condition of the cell cycle and apoptosis. RESULTS ① ODNs labled by FITC mainly gathered in the cell nucleus and the transfection rate was 46.67±5.77%. ② After stimulated by 0.1 fetal bovine serum for 24 hours the inhibition effect of NF-κB decoy ODNs group E2F decoy ODNs group and NF-κB+E2F decoy ODNs group on cellular proliferation was all obvious 34.96±6.35% 38.75±0.14%,49.60±5.07%and the inhibition effect of decoy ODNs group was all stronger than that of the mismatched ODNs group and the inhibition effect of combination application group was stronger than that of single application group P < 0.01. After stimulated by fetal bovine serum for 48 hours NF-κB decoy ODNs group and NF-κB+E2F decoy ODNs group still could obviously inhibit cellular proliferation (36.35±5.24)% 42.60±4.21% but the proliferation of E2F decoy ODNs group was stronger than that of the normal control group (-24.22±9.68)%P < 0.01. ③After stimulated by fetal bovine serum for 24 hours single application group or combination application group of NF-κB and E2F decoy ODNs both could decrease the expression of PCNA. ④The number of cell cycle stayed mainly at DNA synthesis prior phase in groups of NF-κB and /or E2F decoy ODNs was increased and the percent of early apoptosis was also increased. CONCLUSION The decoy ODNs of NF-κB and/or E2F can inhibit the proliferation of vascular smooth muscle cells of porcine cultured primarily while E2F decoy ODNs become ineffective after a short period of time and the inhibition effect may be due to retarding the progress of cell cycle and promoting apoptosis.
The immunomodulatory effects of DNA-conjugated collagen scaffolds on bone healing

Jing-han Song,Jun-ting Gu,Gao-peng Dang,Zhi-ting Li,Chen Lei,Ling Li,Zhao Mu,Franklin R. Tay,Kai Jiao,Li-na Niu

DOI: https://doi.org/10.1016/j.cej.2023.145318

IF: 15.1

2023-10-01

Chemical Engineering Journal

Abstract:Unmodified collagen scaffolds represent a bottleneck in bone tissue engineering. Because of their limited mechanical and osteoinductive properties, these scaffolds do not perform well in repairing large bone defects. To overcome these limitations, a deoxyribonucleic acid-crosslinked collagen scaffold (DNA-Col) is fabricated to enhance healing of bone defects. The DNA-Col induces rapid formation of new bone tissue in a rat alveolar bone defect model. However, the improved osteogenic performance is not directly attributed to DNA-Col, but to the interaction between DNA-Col and T cells. Mechanistic experiments further demonstrate that recruitment of regulatory T cells (Tregs) is significantly triggered by implantation of DNA-Col in vivo. This is supported by the reversal of DNA-Col-induced bone regeneration after depletion of Tregs. These results indicate that Tregs play an important role in DNA-Col-induced new bone formation. Further investigations reveal that DNA-Col promotes Treg differentiation via metabolic reprogramming. These exciting findings establish the role of DNA-Col as a bioactive bone regeneration scaffold via its capability to interact with Tregs. The present study paths the way for creating smart hard tissue engineering materials with modulatory functions on the osteo-immunologic environment of a surgical bone defect.

engineering, chemical, environmental
Nitric Oxide Inhibits Androgen Receptor-Mediated Collagen Production in Human Gingival Fibroblasts

S-J Lin,H-K Lu,H-W Lee,Y-C Chen,C-L Li,L-F Wang

DOI: https://doi.org/10.1111/j.1600-0765.2012.01484.x

2012-01-01

Journal of Periodontal Research

Abstract:Lin S‐J, Lu H‐K, Lee H‐W, Chen Y‐C, Li C‐L, Wang L‐F. Nitric oxide inhibits androgen receptor‐mediated collagen production in human gingival fibroblasts. J Periodont Res 2012; 47: 701–710. © 2012 John Wiley & Sons A/SBackground and Objective: In our previous study, we found that flutamide [an androgen receptor (AR) antagonist] inhibited the up‐regulation of collagen induced by interleukin (IL)‐1β and/or nifedipine in gingival fibroblasts. The present study attempted to verify the role of nitric oxide (NO) in the IL‐1β/nifedipine‐AR pathway in gingival overgrowth.Material and Methods: Confluent gingival fibroblasts derived from healthy individuals (n = 4) and those with dihydropyridine‐induced gingival overgrowth (DIGO) (n = 6) were stimulated for 48 h with IL‐1β (10 ng/mL), nifedipine (0.34 μm) or IL‐1β + nifedipine. Gene and protein expression were analyzed with real‐time RT‐PCR and western blot analyses, respectively. Meanwhile, Sircol dye‐binding and the Griess reagent were, respectively, used to detect the concentrations of total soluble collagen and nitrite in the medium.Results: IL‐1β and nifedipine simultaneously up‐regulated the expression of the AR and type‐I collagen α1 [Colα1(I)] genes and the total collagen concentration in DIGO cells (p < 0.05). IL‐1β strongly increased the expression of inducible nitric oxide synthase (iNOS) mRNA and the nitrite concentration in both healthy and DIGO cells (p < 0.05). However, co‐administration of IL‐1β and nifedipine largely abrogated the expression of iNOS mRNA and the nitrite concentration with the same treatment. Spearman’s correlation coefficients revealed a positive correlation between the AR and total collagen (p < 0.001), but they both showed a negative correlation with iNOS expression and the NO concentration (p < 0.001). The iNOS inhibitor, 1400W, enhanced IL‐1β‐induced AR expression; furthermore, the NO donor, NONOate, diminished the expression of the AR to a similar extent in gingival fibroblasts derived from both healthy patients and DIGO patients (p < 0.05).Conclusion: IL‐1β‐induced NO attenuated AR‐mediated collagen production in human gingival fibroblasts. The iNOS/NO system down‐regulated the axis of AR/Colα1(I) mRNA expression and the production of AR/total collagen proteins by DIGO cells.
18 Alpha-Glycyrrhetinic Acid Down-Regulates Expression Of Type I And Iii Collagen Via Tgf-B1/Smad Signaling Pathway In Human And Rat Hepatic Stellate Cells

Lungen Lu,Lei Zong,Ying Qu,Mingyi Xu,Yuwei Dong

DOI: https://doi.org/10.7150/ijms.4395

2012-01-01

International Journal of Medical Sciences

Abstract:Objective: To investigate the effects of 18 alpha-glycyrrhetinic acid (18 alpha-GA) on the expression of type I and III collagen in human and rat hepatic stellate cells (HSC) and to explore the role of TGF-beta 1/Smad signaling pathway involved.Methods: Following 18 alpha-GA treatment, the cell viability and cell growth were detected to determine the optimal concentration of 18 alpha-GA. The expressions of TGF-beta 1/Smad signaling-related genes including type I and III collagen in human and rat HSCs before and after 18 alpha-GA treatment were measured by real time PCR. The expression of related proteins was verified by western blot assay. The phosphorylation level of Smad2 and Smad3 was detected by immunocytochemistry. The DNA binding activities of SP-1, AP-1 and NF-kappa B were measured by both EMSA and ArrayStar transcription factor activity assay.Results: 18 alpha-GA could decrease the mRNA and protein expression of Smad3, type I and III collagen, increase the Smad7 expression in human and rat HSCs (P<0.05), and reduce phosphorylation level of Smad3 at 24 h and 48 h after treatment. The DNA binding activities of transcription factors were suppressed by 18 alpha-GA in human and rat HSCs at 24 h, and the activities reduced in a time dependent manner with the lowest activities at 48 h, especially for SP-1.Conclusion: 18 alpha-GA could inhibit the mRNA and protein expression of type I and III collagen in human and rat HSCs, which may be attributed to down-regulation of Smad3, up-regulation of Smad7, and inhibition of DNA binding activities of SP-1, AP-1 and NF-kappa B.
STAT3 Decoy Oligodeoxynucleotides Suppress Liver Inflammation and Fibrosis in Liver Cancer Cells and a DDC-Induced Liver Injury Mouse Model

Hye Jin Choi,Young-Ah Kim,Junghwa Ryu,Kwan-Kyu Park,Sun-Jae Lee,Byung Seok Kim,Jeong-En Song,Joo Dong Kim

DOI: https://doi.org/10.3390/molecules29030593

IF: 4.6

2024-01-26

Molecules

Abstract:Liver damage caused by various factors results in fibrosis and inflammation, leading to cirrhosis and cancer. Fibrosis results in the accumulation of extracellular matrix components. The role of STAT proteins in mediating liver inflammation and fibrosis has been well documented; however, approved therapies targeting STAT3 inhibition against liver disease are lacking. This study investigated the anti-fibrotic and anti-inflammatory effects of STAT3 decoy oligodeoxynucleotides (ODN) in hepatocytes and liver fibrosis mouse models. STAT3 decoy ODN were delivered into cells using liposomes and hydrodynamic tail vein injection into 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-fed mice in which liver injury was induced. STAT3 target gene expression changes were verified using qPCR and Western blotting. Liver tissue fibrosis and bile duct proliferation were assessed in animal experiments using staining techniques, and macrophage and inflammatory cytokine distribution was verified using immunohistochemistry. STAT3 decoy ODN reduced fibrosis and inflammatory factors in liver cancer cell lines and DDC-induced liver injury mouse model. These results suggest that STAT3 decoy ODN may effectively treat liver fibrosis and must be clinically investigated.

chemistry, multidisciplinary,biochemistry & molecular biology
[An in Vivo Study on Interlukin-10 Inhibiting the Expression and Secretion of Collagen I and IV in Hepatic Stellate Cells].

Liang-fa Xiong,Xi-sheng Leng,Tao Li,Yu-hua Wei,Ji-run Peng,Yan-tong Guo

DOI: https://doi.org/10.3760/j.issn:1007-3418.2005.06.008

2005-01-01

Abstract:OBJECTIVES:To investigate the effect of interlukin-10 (IL-10) on expression and secretion of collagen I, IV in rat's hepatic stellate cells (HSC) of livers injured by CCl4.METHOD:The adenovirus vector encoded IL-10 gene was used to transfect rats with liver injury via the caudal veins. HSC were isolated and purified from the rat livers by collagenase IV perfusion and density gradient centrifugation with Nycodenz. The expression of collagen I, IV mRNA in HSC was detected by semi-quantitative RT-PCR method and the secretion of collagen I, IV in culture serum of HSC by ELISA method. The quantity of collagen was measured in the van Gieson stained histological liver preparations.RESULTS:The expression and secretion of collagen I, IV in the adenovirus vector encoding IL-10 gene group were significantly lower than those in the adenovirus vector without IL-10 gene group and the control group (P < 0.05). The quantity of collagen in the treatment group was lower than that in the control group.CONCLUSION:IL-10 can inhibit collagen I, IV expression and secretion in rat HSC.
Controlling Fibrous Capsule Formation Through Long-Term Down-Regulation of Collagen Type I (COL1A1) Expression by Nanofiber-Mediated Sirna Gene Silencing.

Pim-on Rujitanaroj,Brian Jao,Junghoon Yang,Feng Wang,James M. Anderson,Jun Wang,Sing Yian Chew

DOI: https://doi.org/10.1016/j.actbio.2012.09.029

IF: 10.633

2012-01-01

Acta Biomaterialia

Abstract:The foreign body reaction often interferes with the long-term functionality and performance of implanted biomedical devices through fibrous capsule formation. While many implant modification techniques have been adopted in attempts to control fibrous encapsulation, the outcomes remained sub-optimal. Nanofiber scaffold-mediated RNA interference may serve as an alternative approach through the localized and sustained delivery of siRNA at implant sites. In this study, we investigated the efficacy of siRNA–poly(caprolactone-co-ethylethylene phosphate) nanofibers in controlling fibrous capsule formation through the down-regulation of collagen type I (COL1A1) in vitro and in vivo. By encapsulating complexes of COL1A1 siRNA with a transfection reagent (Transit TKO) or the cell penetrating peptides CADY or MPG within the nanofibers (550–650nm in diameter), a sustained release of siRNA was obtained for at least 28days (loading efficiency ∼60–67%). Scaffold-mediated transfection significantly enhanced cellular uptake of oligonucleotides and prolonged in vitro gene silencing duration by at least 2–3 times as compared to conventional bolus delivery of siRNA (14days vs. 5–7days by bolus delivery). In vivo subcutaneous implantation of siRNA scaffolds revealed a significant decrease in fibrous capsule thickness at weeks 2 and 4 as compared to plain nanofibers (p<0.05). Taken together, the results demonstrated the efficacy of scaffold-mediated siRNA gene-silencing in providing effective long-term control of fibrous capsule formation.
Effect of Smad4 siRNA on transforming growth factor-beta-induced-type Ⅰ collagen expression

Guo Bao-liang,Yan Zhao-qi,Zhong Lei,Zhang Jian-guo,Yang Xue-wei

2009-01-01

Abstract:BACKGROUND:Previous study demonstrates that blocking smad transduction pathway can be served as a new target for blocking transforming growth factorβ(TGF-β)induced hepatic fibrosis.OBJECTIVE:To verify the effect of smad4 small interference RNA(siRNA)on TGF-β-induced type Ⅰ collagen expression.DESIGN,TIME AND SETTING:A single sample observation was performed at the College of Pharmacy,Harbin Medical University from September 2006 to October 2008.MATERIALS:Hepatic stellate cell(HSC-T6)was cultured in vitro,siRNA and luciferase reporter gene was transfected with Lipofectamine reagent,cytomegalovirus-β-galactosidase was served as the positive control group.METHODS:According to the different treatment,cells were divided into blank control,Smad4 siRNA transfection,TGF-βand TGF-βfollowing Smad4 siRNA transfection groups.All cells were collected at 24 hours after culture.MAIN OUTCOME MEASURES:The activities of Smad binding element(SBE)reporter was measured by luciferase reporter assays.Expression changes of type Ⅰ collagen mRNA was determined by RT-PCR,and protein changes were detected by Western blot analysis.RESULTS:Smad4 siRNA abrogated the Smad4 protein expression.Smad4 siRNA suppressed TGF-β1-induced 4×SBE luciferase reporter activity.Smad4 siRNA inhibited TGF-β1-induced type Ⅰ collagen mRNA and protein expression.CONCLUSION:Smad4 siRNA can effectively block type Ⅰ collagen mRNA expression induced by TGF-β1.
Decoy oligodeoxynucleotides: A promising therapeutic strategy for inflammatory skin disorders

Maryam Mahjoubin-Tehran,Samaneh Rezaei,Sercan Karav,Prashant Kesharwani,Amirhossein Sahebkar

DOI: https://doi.org/10.1016/j.humimm.2024.111161

2024-10-24

Abstract:Chronic inflammatory skin conditions such as psoriasis and atopic dermatitis (AD) impose a significant burden on both the skin and the overall well-being of individuals, leading to a diminished quality of life. Despite the use of conventional treatments like topical steroids, there remains a need for more effective and safer therapeutic options to improve the lives of patients with severe skin conditions. Molecular therapy has emerged as a promising approach to address disorders such as atopic dermatitis, psoriasis, and contact hypersensitivity. One strategy to counteract the disease processes involves targeting the transcriptional process. A novel form of gene therapy utilizes double-stranded oligodeoxynucleotides (ODNs), also known as decoys, that contain cis-elements. By introducing these decoy ODNs through transfection, the cis-trans interactions are disrupted, leading to the inhibition of trans-factors from binding to the intrinsic cis-elements and thus regulating gene expression. In this review, we have summarized studies investigating the therapeutic effects of decoy ODNs on inflammatory skin diseases. Various transcription factors, including NF-kB, STAT6, HIF-1α/STAT5, STAT1, and Smad, have been targeted and inhibited using designed decoy ODNs for the treatment of atopic dermatitis, psoriasis, hypertrophic scarring, and contact hypersensitivity. The findings of these studies confirm the significant potential of the decoy approach in the treatment of inflammatory skin diseases.

[An experimental study of inhibiting effect of decoy oligodeoxynucleotides on the gene expression of collagen in NIH3T3 cell].

Decoy Oligonucleotide Rescues IGF1R Expression from MicroRNA-223 Suppression.

Effect of Decoy Oligonucleotides of Nuclear Factor-kB on Intercellular Adhesion Molecule-1 Expression in Human Vascular Endothelial Cells

The study of nuclear factor kappa B decoy oligodeoxyribonucleotide on NO production of chondrocytes induced by IL-1β

RNAi-mediated inhibition of COL1A1 and COL3A1 in human skin fibroblasts.

Suppression of cell proliferation and collagen production in cultured human hypertrophic scar fibroblasts by Sp1 decoy oligodeoxynucleotide.

Selective Inhibition of Collagen Gene Expression in Fibroblasts by an Interferon-Gamma Transgene

Transfection of Nuclear Factor-Κb Decoy Oligodeoxynucleotide Inhibits Inflammatory Factors Expression in Renal Tubular Epithelial Cells

Inhibition of COL1A1 and COL3A1 Expression by RNA Interference in Human Skin Fibroblasts

Ultrasound-driven nanosilicon transfected tobacco cell as robust factory for collagen III protein synthesis

Anti-Oxidant Gene Therapy by NFkB Decoy Oligodeoxynucleotide

[Influence of Nuclear Factor-Kappab Decoy Transfection on Nuclear Factor-Kappab Activity and Vascular Endothelial Growth Factor/urokinase-Type Plasminogen Activator/intercellular Cell Adhesion Molecule-1 Level of SKOV3 Cells].

Inhibitive effect of decoy oligonucleotides of transcription factor NF-κB and E2F on the proliferation of vascular smooth muscle cells

The immunomodulatory effects of DNA-conjugated collagen scaffolds on bone healing

Nitric Oxide Inhibits Androgen Receptor-Mediated Collagen Production in Human Gingival Fibroblasts

18 Alpha-Glycyrrhetinic Acid Down-Regulates Expression Of Type I And Iii Collagen Via Tgf-B1/Smad Signaling Pathway In Human And Rat Hepatic Stellate Cells

STAT3 Decoy Oligodeoxynucleotides Suppress Liver Inflammation and Fibrosis in Liver Cancer Cells and a DDC-Induced Liver Injury Mouse Model

[An in Vivo Study on Interlukin-10 Inhibiting the Expression and Secretion of Collagen I and IV in Hepatic Stellate Cells].

Controlling Fibrous Capsule Formation Through Long-Term Down-Regulation of Collagen Type I (COL1A1) Expression by Nanofiber-Mediated Sirna Gene Silencing.

Effect of Smad4 siRNA on transforming growth factor-beta-induced-type Ⅰ collagen expression

Decoy oligodeoxynucleotides: A promising therapeutic strategy for inflammatory skin disorders